Abstract
Not paying for a drug unless it works sounds great for patients and healthcare funders, but it could also benefit manufacturers.
MeSH terms
-
Drug Industry / economics
-
Fees, Pharmaceutical*
-
Health Policy
-
Humans
-
Pharmaceutical Preparations / economics*
-
Treatment Failure
Substances
-
Pharmaceutical Preparations